Korean J Dermatol.  1997 Aug;35(4):772-777.

A Case of Angiocentic T-Cell Lymphoma Achieving Initial Complete Remission with CVP Chemotherapy

• Yang JK
• Kim SW
• paik SC
• Kim CW
• Park SY

Abstract

Angiocentric T-cell lymphoma is a subtype of peripheral T-cell lymphoma and histologically characterized by angiocentric and angioinvasive infiltration of lymphoid cells with varying degrees of cytological atypia, leading to angiodestruction. This disease represents the malignant end in the histological spectrum of angiocentric immunproliferative lesions. This malignancy is commonly a disease with considerable morbidity and is often fatal. However, primary cutaneous angiocentric T-cell lymphoma has a tendency to give a favorable prognosis. Epstein-Barr virus can be identified in involved tissue by immunostaining or by in situ hybridization and it is considered significant in the prognosis. We report a case of cutaneous angiocentric T-cell lymphoma, where the Epstein-Barr virus was identified within neoplastic cells. CVP(cyclophosphamide, vincristine, prednisone) chemotherapy was instigated and an initial complete remission was achieved.

Keyword

Angiocentric T cell ymphoma; CVP chemotherapy

MeSH Terms

Drug Therapy*
Herpesvirus 4, Human
In Situ Hybridization
Lymphocytes
Lymphoma, T-Cell*
Lymphoma, T-Cell, Peripheral
Prognosis
T-Lymphocytes*
Vincristine
Vincristine